创世大发app下载安装

彩神主页

Home/Investors/ Press Releases

彩神主页

  • Company Information
  • Financial Information
  • Stock Data
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
    • 9Aug

    CymaBay Reports Second Quarter 2018 Financial Results and Provides Corporate Update彩神主页

    2Aug

    CymaBay to Report Second Quarter 2018 Financial Results on Thursday, August 9彩神主页

    25Jun

    CymaBay Therapeutics Added to the Russell 3000® and Russell 2000® Indexes彩神主页

    19Jun

    CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018彩神主页

    8May

    CymaBay Reports First Quarter 2018 Financial Results and Provides Corporate Update彩神主页

    8May

    CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis彩神主页

    1May

    CymaBay to Report First Quarter 2018 Financial Results on Tuesday, May 8彩神主页

    11Apr

    CymaBay Announces Positive New 12-Week and 26-Week Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis at The International Liver Congress™ 2018彩神主页

    15Mar

    CymaBay Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Corporate Update彩神主页

    6Mar

    CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15彩神主页

    RSS
    Show All

    彩神主页

    • 7575 Gateway Blvd., Suite 110
      Newark, CA 94560
    • +1 (510) 293-8800
    • +1 (510) 293-9090

    彩神主页

    彩神主页

    昌盛国际最专业的电子游戏平台彩运通彩票官网诚信彩票手机版创世大发下载链接创世大发登录诚信彩票官方版